CNTB (STOCKS)
Connect Biopharma Holdings Limited Ordinary Shares
$2.680000
+0.030000 (+1.13%)
Prev close: $2.650000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Barry D. Quart
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $164.36M
- Employees
- 62
- P/E (TTM)
- -9.47
- P/B (TTM)
- 2.70
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $762.00K |
| Benefits Costs and Expenses | $49.76M |
| Costs And Expenses | $49.76M |
| Nonoperating Income/Loss | $3.17M |
| Operating Expenses | $52.93M |
| Research and Development | $32.75M |
| Other Operating Expenses | $20.18M |
| Operating Income/Loss | -$52.17M |
| Income/Loss From Continuing Operations After Tax | -$49.28M |
| Income/Loss From Continuing Operations Before Tax | -$49.00M |
| Income Tax Expense/Benefit | $276.00K |
| Net Income/Loss | -$49.28M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$49.28M |
| Net Income/Loss Available To Common Stockholders, Basic | -$49.28M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.89 |
| Diluted Earnings Per Share | -$0.89 |
| Basic Average Shares | 55,555,000 |
| Diluted Average Shares | 55,555,000 |
| Assets | $67.36M |
| Current Assets | $62.60M |
| Cash | $54.80M |
| Prepaid Expenses | $6.45M |
| Other Current Assets | $1.34M |
| Noncurrent Assets | $4.76M |
| Fixed Assets | $3.94M |
| Other Non-current Assets | $829.00K |
| Liabilities | $11.99M |
| Current Liabilities | $11.43M |
| Accounts Payable | $1.99M |
| Wages | $2.10M |
| Other Current Liabilities | $7.33M |
| Noncurrent Liabilities | $563.00K |
| Equity | $55.37M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $55.37M |
| Liabilities And Equity | $67.36M |
| Net Cash Flow From Operating Activities | -$42.28M |
| Net Cash Flow From Operating Activities, Continuing | -$42.28M |
| Net Cash Flow From Investing Activities | -$16.93M |
| Net Cash Flow From Investing Activities, Continuing | -$16.93M |
| Net Cash Flow From Financing Activities | $484.00K |
| Net Cash Flow From Financing Activities, Continuing | $484.00K |
| Exchange Gains/Losses | -$626.00K |
| Net Cash Flow | -$59.35M |
| Net Cash Flow, Continuing | -$58.72M |
| Comprehensive Income/Loss | -$49.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$49.97M |
| Other Comprehensive Income/Loss | -$49.97M |